Sensi Seeds
DECEMBER 10, 2018
The study in question, published on October 8 2018 in the Population Health Management journal, is entitled Trends in Publications on Medical Cannabis from the Year 2000. Consequently, they sorted the publications into three main groups: psychiatry, cancer treatment, and neurology.
The Joint Blog
APRIL 21, 2020
The study’s abstract can be found below: Considering data from in vitro and in vivo studies, cannabidiol (CBD) seems to be a promising candidate for the treatment of both somatic and psychiatric disorders.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
DECEMBER 1, 2021
Vilmarie Fraguada Narloch, PsyD, is a licensed clinical psychologist in Chicago, Illinois, focusing on integrated treatment of co-occurring mental health and substance use disorders and psychedelic-assisted therapy. Kylea Taylor, M.S., Kylea started studying with Stanislav Grof, M.D.
Veriheal
OCTOBER 29, 2020
billion was funded into cannabis research between 2000 and 2018. On the brighter side, Science Magazine has indicated that the funding for cannabis as an effective form of treatment and therapy is rising, however not as much as the funding for its adverse impacts are. How could we move the focus towards understanding the benefits?
Cannabis Law Report
JULY 19, 2021
Collectively, between the two organizations we offer a full-service package from protocol development to timely and successful clinical trial execution.”. LMC Manna has more than 25 years of clinical research experience having worked on more than 2000 clinical trials in over 30 therapeutic indications.
The Blunt Truth
AUGUST 13, 2019
The public hearing attracted over 100 speakers and 2000 participants. The FDA is collecting data to fill these gaps. In each instance, the companies were selling products with flagrant disease-related claims that the FDA had not approved for the treatment or prevention of any ailments. What’s Next?
The Cannigma
FEBRUARY 11, 2021
One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. All I’m doing is collecting the data.
Expert insights. Personalized for you.
81 
Let's personalize your content